PEAPACK GLADSTONE FINANCIAL CORP
Position in PVLA — Palvella Therapeutics, Inc.
CIK 1050743
BEDMINSTER, NJ
Position in PVLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$897,817
+$324,427 QoQ
Shares Held
5,875
+27.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#101
of 196 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PVLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $4,960,618 across 6 Biotechnology names. PVLA ranks #2 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,837 | $1,768,982 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
This page
|
5,875 | $897,817 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
10,950 | $857,056 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,654 | $821,591 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,988 | $381,125 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
13,451 | $234,047 |
All Filings in PVLA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $897,817 | 5,875 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $573,390 | 4,600 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $314,010 | 3,000 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||